FR2747676B1 - Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique - Google Patents

Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique

Info

Publication number
FR2747676B1
FR2747676B1 FR9605000A FR9605000A FR2747676B1 FR 2747676 B1 FR2747676 B1 FR 2747676B1 FR 9605000 A FR9605000 A FR 9605000A FR 9605000 A FR9605000 A FR 9605000A FR 2747676 B1 FR2747676 B1 FR 2747676B1
Authority
FR
France
Prior art keywords
sulfonylamino
oxo
ethyl
preparation
therapeutic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9605000A
Other languages
English (en)
Other versions
FR2747676A1 (fr
Inventor
Gerard Cremer
Pascale Goberville
Christian Hoornaert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9605000A priority Critical patent/FR2747676B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to CA002250747A priority patent/CA2250747A1/fr
Priority to KR1019980708470A priority patent/KR20000010594A/ko
Priority to EP97920783A priority patent/EP0900224A1/fr
Priority to IL12591897A priority patent/IL125918A0/xx
Priority to BR9708814A priority patent/BR9708814A/pt
Priority to PCT/FR1997/000700 priority patent/WO1997040052A1/fr
Priority to JP09537780A priority patent/JP2001500842A/ja
Publication of FR2747676A1 publication Critical patent/FR2747676A1/fr
Application granted granted Critical
Publication of FR2747676B1 publication Critical patent/FR2747676B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9605000A 1996-04-22 1996-04-22 Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique Expired - Fee Related FR2747676B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9605000A FR2747676B1 (fr) 1996-04-22 1996-04-22 Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
KR1019980708470A KR20000010594A (ko) 1996-04-22 1997-04-18 프로파르길글리신 유도체, 그것의 제조방법 및 합성 중간물질로서의 그것의 사용
EP97920783A EP0900224A1 (fr) 1996-04-22 1997-04-18 Derives de propargylglycine, leur preparation et leur utilisation comme intermediaires de synthese
IL12591897A IL125918A0 (en) 1996-04-22 1997-04-18 Propargylgycine derivatives preparation and utilisation thereof as synthesis intermediates
CA002250747A CA2250747A1 (fr) 1996-04-22 1997-04-18 Derives de propargylglycine, leur preparation et leur utilisation comme intermediaires de synthese
BR9708814A BR9708814A (pt) 1996-04-22 1997-04-18 Derivados de propargilglicina seu preparo e sua utilização como intermediários de sintese
PCT/FR1997/000700 WO1997040052A1 (fr) 1996-04-22 1997-04-18 Derives de propargylglycine, leur preparation et leur utilisation comme intermediaires de synthese
JP09537780A JP2001500842A (ja) 1996-04-22 1997-04-18 プロパルギルグリシン誘導体、その製造法および合成中間体としてのその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9605000A FR2747676B1 (fr) 1996-04-22 1996-04-22 Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2747676A1 FR2747676A1 (fr) 1997-10-24
FR2747676B1 true FR2747676B1 (fr) 1998-06-05

Family

ID=9491426

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9605000A Expired - Fee Related FR2747676B1 (fr) 1996-04-22 1996-04-22 Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique

Country Status (1)

Country Link
FR (1) FR2747676B1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48623B1 (en) * 1978-08-31 1985-03-20 Mitsubishi Chem Ind Alpha-(n-arylsulfonyl-l-argininamides,processes for their preparation and pharmaceutical compositions containing these substances
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
DE4424828A1 (de) * 1994-07-14 1996-01-18 Thomae Gmbh Dr K Neue substituierte Arylsulfonamide, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
FR2747676A1 (fr) 1997-10-24

Similar Documents

Publication Publication Date Title
FR2786769B1 (fr) Derives de 2,5-diazabicyclo[2.2.1]heptane, leur preparation et leur application en therapeutique
FR2790474B1 (fr) Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2756563B1 (fr) Derives de benzoate de 1,4-diazabicyclo[2.2.2]oct-2-yl- methyle, leur preparation et leur application en therapeutique
MA22981A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique.
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2753970B1 (fr) Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
FR2728570B1 (fr) Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2765874B1 (fr) Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique
FR2772377B1 (fr) Derives de 1-(1-h-imidazol-2-yl)pyrrolidines et 1-(1-h-imidazol-2-ylpiperidines), leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2752839B1 (fr) Derives de benzofurane, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2785903B1 (fr) Derives de 1-aminoethylquinoleine, leur preparation et leur application en therapeutique
FR2747676B1 (fr) Derives de [1-oxo-2-(sulfonylamino)ethyl] piperidine, leur preparation et leur application en therapeutique
FR2765580B1 (fr) Derives de (1h-imidazol-4-yl)piperidine, leur preparation et leur application en therapeutique
FR2777566B1 (fr) Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2754261B1 (fr) Derives de quinuclidine, leur preparation et leur application en therapeutique
FR2759698B1 (fr) Derives de 1,4-diphenylimidazole-5-acetamide, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20051230